EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Cold atmospheric plasma therapy for Malassezia folliculitis: Laboratory investigations and a randomized clinical trial

Na Wang iD, Tingting Yan, Xiaole Mei, Jia Liu, Yilong Lei, Chunjun Yang iD

Skin Research and Technology · 2024

DOI: 10.1111/srt.13850 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Na Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Malassezia, Folliculitis, Plasma Gases, Antifungal Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Fund of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current treatment options for Malassezia folliculitis (MF) are limited. Recent research has demonstrated the inhibitory effect of cold atmospheric plasma (CAP) on the growth of Malassezia pachydermatis in vitro, suggesting CAP as a potential therapeutic approach for managing MF.

Objectives

The objective of our study is to assess the in vitro antifungal susceptibility of Malassezia yeasts to CAP. Additionally, we aim to evaluate the efficacy and tolerability of CAP in treating patients with MF.

Methods

We initially studied the antifungal effect of CAP on planktonic and biofilm forms of Malassezia yeasts, using well‐established techniques such as zone of inhibition, transmission electron microscopy, colony count assay and 2,3‐bis(2‐methoxy‐4‐nitro‐5‐sulfophenyl)‐2H‐tetrazolium‐5‐carboxanilide salt assay. Subsequently, a randomized (1:1 ratio), active comparator‐controlled, observer‐blind study was conducted comparing daily CAP therapy versus itraconazole 200 mg/day for 2 weeks in 50 patients with MF. Efficacy outcomes were measured by success rate, negative microscopy rate and changes in Dermatology Life Quality Index (DLQI) and Global Aesthetic Improvement Scale (GAIS) scores. Safety was assessed by monitoring adverse events (AEs) and local tolerability.

Results

In laboratory investigations, CAP time‐dependently inhibited the growth of Malassezia yeasts in both planktonic and biofilm forms. Forty‐nine patients completed the clinical study. At week 2, success was achieved by 40.0% of subjects in the CAP group versus 58.3% in the itraconazole group ( p = 0.199). The negative direct microscopy rates of follicular samples were 56.0% in the CAP group versus 66.7% in the itraconazole group ( p = 0.444). No significant differences were found in the proportion of subjects achieving DLQI scores of 0/1 ( p = 0.456) or in the GAIS responder rates ( p = 0.588) between the two groups. Three patients in the CAP group and one patient in the itraconazole group reported mild AEs.

Conclusion

CAP demonstrated significant antifungal activity against Malassezia yeasts in vitro and exhibited comparable efficacy to itraconazole in treating MF patients. Without the associated adverse effects of oral antifungal drugs, CAP can be considered a promising and safe treatment modality for MF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MalasseziaFolliculitisPlasma GasesAntifungal AgentsDermatomycosesHumansAdultFemaleMaleMiddle AgedItraconazoleYoung AdultTreatment OutcomeBiofilms

Stichwörter der Autor:innen

MalasseziaMalassezia folliculitisantifungal agentscold atmospheric plasmaitraconazole

Substanzen

Plasma GasesAntifungal AgentsItraconazole

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • The First Clinical College of Anhui Medical University, Hefei, China.

ORCID-Profile: Na Wang, Chunjun Yang

Förderung

  • Research Fund of Anhui Medical University

Zitieren

APA

Wang, N., Yan, T., Mei, X., Liu, J., Lei, Y., & Yang, C. (2024). Cold atmospheric plasma therapy for Malassezia folliculitis: Laboratory investigations and a randomized clinical trial. Skin Research and Technology. https://doi.org/10.1111/srt.13850

Vancouver

Wang N, Yan T, Mei X, Liu J, Lei Y, Yang C. Cold atmospheric plasma therapy for Malassezia folliculitis: Laboratory investigations and a randomized clinical trial. Skin Research and Technology. 2024. doi:10.1111/srt.13850

BibTeX
@article{Wang2024,
  author = {Wang, Na and Yan, Tingting and Mei, Xiaole and Liu, Jia and Lei, Yilong and Yang, Chunjun},
  title = {Cold atmospheric plasma therapy for Malassezia folliculitis: Laboratory investigations and a randomized clinical trial},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13850}
}
Kostenlos starten →